Population
Normal individuals and patients stabilized on oral anticoagulants
Comparison
Commercial recombinant thromboplastin vs Two International Reference Preparations from…
Design
Other
Authors
Loading...
May support standardized INR monitoring with this reagent; leaves open prospective outcome validation in diverse cohorts.
A commercial recombinant thromboplastin fulfills WHO requirements for calibration against International Reference Preparations, demonstrating acceptable precision for monitoring oral anticoagulant therapy.
Tripodi et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: